Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study

by Russell, T.W. et al
3rd September 2025 • 0 comments

Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines

by Murray, Sam et al
29th August 2025 • 0 comments

Adults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study

by Kwesi-Maliepaard, E.M et al
28th May 2025 • 0 comments

Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclasses

by Jerry C. H. Tam, et al.
9th May 2025 • 0 comments

Southeast Asia Social, Ethical and Engagement Aspects of Pandemic Preparedness Workshop

by SEACOVARIANTS

A recap on the SCOPE project's public engagement workshop held 18-19 February 2025 in Da Nang, Vietnam

21st March 2025 • 0 comments

Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic

by Wilhelm Furnon et al.
21st February 2025 • 0 comments

Estimating Population Immunity to SARS-CoV-2 by Random Sampling from Primary and Secondary Healthcare

by Sam Scott et al.
21st February 2025 • 0 comments

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya

by Doreen Lugano, Bernadette Kutima, Makobu Kimani, Antipa Sigilai, John Gitonga, Angela Karani,, Donald Akech, Boniface Karia, Abdhalah K. Ziraba, Angela Maina, Arnold Lambisia, Donwilliams Omuoyo, Daisy Mugo, Ruth Lucinde, Sharon Owuor, Gloria Konyino, Joseph Newman, Dalan Bailey,, Eunice Nduati, George Githinji, Charles N. Agoti, Philip Bejon, J. Anthony G. Scott,, Ambrose Agweyu, Wangeci Kagucia, George M. Warimwe, Charles Sande, Lynette I. Ochola-Oyier, James Nyagwange
10th January 2025 • 0 comments

Chronogram: an R package for data curation and analysis of infection and vaccination cohort studies

by David Greenwood et al.
12th December 2024 • 0 comments

Open Letter: Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium

by Le Nguyen Truc Nhu et al.
14th August 2024 • 0 comments

How scientists are racing to understand the new Mpox strain in the Democratic Republic of the Congo

by Linda Geddes

A previously unknown strain of Mpox is spreading near DRC’s border with Uganda, Burundi and Rwanda. Linda Geddes spoke to Leandre Murhula Masirika, Jean Claude Udahemuka and Trudie Lang who are working to understand and contain the virus.

31st July 2024 • 0 comments

Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2

by Mariana O Diniz et al
21st May 2024 • 0 comments

High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia

by Sheikh Jarju et al.
21st May 2024 • 0 comments

Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation

by Alex Sigal et al
22nd April 2024 • 0 comments

Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant

by Alex Sigal et al
22nd April 2024 • 0 comments

Lessons from Rwanda: Building systems to protect against infectious diseases and biothreats

by World Economic Forum
12th March 2024 • 0 comments

Extending EpiEstim to estimate the transmission advantage of pathogen variants in real-time: SARS-CoV-2 as a case-study

by Sangeeta Bhatia et al
12th March 2024 • 0 comments

Non-pharmaceutical interventions and the emergence of pathogen variants

by Ben Ashby, Cameron A Smith, Robin N Thompson
12th March 2024 • 0 comments

Sample size calculations for pathogen variant surveillance in the presence of biological and systematic biases

by Shirlee Wohl et al
12th March 2024 • 0 comments

Emerging pathogen evolution

by Camille Bonneaud, Ben Longdon
12th March 2024 • 0 comments